BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Hippocampus
,
Anticancer prodrugs
,
Lovastatin
,
rs3825942
,
VEGFA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
T- cell antigen receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Regulatory T (Treg) cells and conventional T cells reponses to different factors and conditions
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
CD4 T-cells with MTOR, ZAP70 silencing, or treated with Rapamycin or Cyclosporin A
Explore Curated Studies Results
Literature
Most Relevant Literature
tidytcells: standardizer for TR/MH nomenclature.
High-sensitive spatially resolved T cell receptor sequencing with SPTCR-seq.
Deep autoregressive generative models capture the intrinsics embedded in T-cell receptor repertoires…
Characterization of T cell receptor repertoire in penile cancer.
Challenges and solutions for therapeutic TCR-based agents.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Agains…
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Ma…
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma T…
T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ